J&J witness testifies in metal-hip lawsuit trial; Boston Scientific seeks zoning changes for new HQ;

 @FierceMedDev: Work advances on early-detection ovarian cancer blood Dx. Story | Follow @FierceMedDev

 @MarkHFierce: J&J faces possible punitive damages in the first verdict regarding faulty vaginal mesh. Thousands of cases to come. Report | Follow @MarkHFierce

 @DamianFierce: The device industry is urging lawmakers to settle on a budget and, of course, repeal the device tax. Article | Follow @DamianFierce

> A witness for Johnson & Johnson ($JNJ) testified that infection rather than a defect forced a patient to have replacement surgery for his ASR metal-on-metal hip. Story

> Boston Scientific ($BSX) is seeking zoning changes to accommodate plans to move its corporate headquarters to Marlborough, MA. Story

> The FDA slapped Woo Young Medical in South Korea with a warning letter, citing the company for quality system violations regarding the manufacturing of its elastomeric infusion pumps. Letter

> The Arizona Heart Foundation is sponsoring U.S clinical trials for a multilayer flow modulator stent made by Cardiatis in Belgium. Story

> With breast cancer cases on the rise, Frost & Sullivan predicts a modest growth in demand for breast-imaging equipment. Item

> Philips is mulling a name change to better reflect the company's diverse business lines, which range from healthcare to lighting and consumer health. Story

> Tandem Diabetes Care won FDA clearance for its t:connect diabetes-management program, a web-based data management system for its t:slim insulin pump. Release

Biotech News

 @FierceBiotech: From FierceVaccines.com: Is it too soon to quit on Nabi's nicotine vaccine? More | Follow @FierceBiotech

 @JohnCFierce: Optimer shares spiking with CEO turned out and the board looking for a buyer. Release | Follow @JohnCFierce

 @RyanMFierce: What Facebook and Google billionaires could do for overlooked biotech brains. Item | Follow @RyanMFierce

> Shionogi wins FDA approval on Osphena for painful sex. Story

> Vertex plots a race through PhIII for 'breakthrough' combo CF therapy. Report

> Jazz strikes up a $120M Concert Pharma collaboration on next-gen Xyrem. More

> Roche follows GSK in move to unlock its data vault on drugs. Article

Pharma News

 @FiercePharma: Allergan settles Botox case in OK. Article | Follow @FiercePharma

 @EricPFierce: AstraZeneca manager accused of getting home makeover at the company's cost. Sunroom, new kitchen, bathroom fixtures. Story | Follow @EricPFierce

> Hospira issues three recalls as it faces crucial FDA inspection. Item

> FDA halts pediatric study of Amgen's Sensipar after death. Story

> India may kill compulsory licensing based on price. More

Drug Delivery News

 @MichaelGFierce: Sanofi's Genzyme hits target with muscular dystrophy RNA drug in mice. Article | Follow @MichaelGFierce

> Ocular Therapeutix submits cataract-surgery sealant for FDA approval. Story

> Synthetic protein tricks immune system for drug delivery, device safety. News

> SHL ups Taiwanese auto injector production by $40M. More

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.